IP Verse

Baxalta competitive analysis

Latest oppositions filed by Baxalta

Explore patent oppositions filed by Baxalta against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2337849
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionSIMIONIMar 12, 2019
EP2634243
Improved Process For The Culturing Of CellsDPXMay 30, 2018
EP2261230
Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 12, 2018
EP2634242
Improved Process For The Culturing Of CellsDPXDec 21, 2017
EP2634250
Improved Process For The Culturing Of CellsDPXDec 21, 2017
EP2483304
Pre-Filtration Adjustment Of Buffer SolutesF HOFFMANN LA ROCHEJan 30, 2017
EP2343362
Improved Process For The Culturing Of CellsDPXDec 23, 2016
EP1561756
Method Of Purifying ProteinCHUGAI SEIYAKU KABUSHIKI KAISHASep 23, 2016
EP1673452
Method For Large-Scale Production Of A Polypeptide In Eukaryote Cells And A Culture Vessel Suitable ThereforNOVO NORDISK HEALTH CARESep 23, 2016
EP2041259
Improved Process For The Culturing Of CellsDPXJul 14, 2016

Latest patents of Baxalta opposed by its competitors

Explore Baxalta's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3064508
Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture1
EP2467399
Feb 1, 2023Purification Of Vwf For Increased Removal Of Non-Lipid Enveloped Viruses1
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3277718
Mar 24, 2021Dosage Regimen For Anti-Mif Antibodies1
EP3121266
Apr 22, 2020Oligopeptide-Free Cell Culture Media9
EP2739641
Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes2
EP3116534
May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders1
EP2356247
May 15, 2019Method Of Producing Serum-Free Insulin-Free Factor Vii1
EP2652491
Nov 29, 2017Eluate Collection Using Conductivity Gradient1
EP2295547
Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression1

Latest PTAB cases involving Baxalta

Discover the latest PTAB cases involving Baxalta, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Baxalta with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAXALTA2027 - -
DPX - 18 - -
DSM ASSETS33167 - 15
NOVO NORDISK HEALTH CARE - 7 - -